Goldman Sachs Group set a €33.50 ($38.95) target price on Vivendi (EPA:VIV) in a research report released on Monday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
A number of other analysts have also recently issued reports on VIV. UBS Group set a €32.00 ($37.21) price objective on shares of Vivendi and gave the stock a buy rating in a research note on Friday, January 17th. Deutsche Bank set a €37.00 ($43.02) target price on shares of Vivendi and gave the company a buy rating in a research note on Tuesday, November 19th. Barclays set a €28.50 ($33.14) target price on shares of Vivendi and gave the company a buy rating in a research note on Monday, December 9th. Credit Suisse Group set a €30.10 ($35.00) target price on shares of Vivendi and gave the company a buy rating in a research note on Wednesday, December 11th. Finally, JPMorgan Chase & Co. set a €43.00 ($50.00) target price on shares of Vivendi and gave the company a buy rating in a research note on Wednesday, December 11th. Two equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company presently has a consensus rating of Buy and a consensus target price of €31.36 ($36.47).
Shares of EPA VIV opened at €24.98 ($29.05) on Monday. The firm has a fifty day moving average price of €25.42 and a 200-day moving average price of €25.11. Vivendi has a 1 year low of €16.85 ($19.59) and a 1 year high of €24.87 ($28.92).
Vivendi SA operates as a content media and communication company in France, rest of Europe, the Americas, Asia/Oceania, and Africa. It operates through Universal Music Group, Canal+ Group, Havas, Gameloft, Vivendi Village, and New Initiatives segments. The Universal Music Group segment engages in the sale of digital and physical recorded music; and exploitation of music publishing rights, as well as provision of artist and merchandising services.
Recommended Story: Cash Flow
Receive News & Ratings for Vivendi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivendi and related companies with MarketBeat.com's FREE daily email newsletter.